Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 13 of 13)As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
1-Feb-10Hilliard LyonsStephen A. O'NeilRecovery from Weak 2008 Complete with 2009 EPS Up 61%11$254 Stars 4 Stars View Abstract
1-Feb-10Hilliard LyonsStephen A. O'NeilOrganic Declines Slowing9$254 Stars 4 Stars View Abstract
29-Jan-10Hilliard LyonsStephen A. O'NeilStrong Results from BMY's Core Pharmaceuticals Business. Last of the Non-drug Units Divested.7$254 Stars 4 Stars View Abstract
29-Jan-10Hilliard LyonsStephen A. O'NeilMid-teens Growth in Asia/Latin America. Margins Still Impressive Despite Promotional Spending.8$254 Stars 4 Stars View Abstract
28-Jan-10Hilliard LyonsStephen A. O'NeilStrong Finish to 20098$254 Stars 4 Stars View Abstract
28-Jan-10Hilliard LyonsStephen A. O'NeilLong-term Growth from Many Sources10$254 Stars 4 Stars View Abstract
27-Jan-10Hilliard LyonsStephen A. O'NeilFourth Quarter Revenue Benefited from Positive Currency Effects. EPS Better Than Expected.9$254 Stars 4 Stars View Abstract
27-Jan-10Hilliard LyonsStephen A. O'NeilStrong Fourth Quarter Results. Some Optimism for Housing in 2010. Price Target Increased.9$254 Stars 4 Stars View Abstract
26-Jan-10Hilliard LyonsStephen A. O'NeilMargins Holding in the First Fiscal Quarter as Certain Businesses Improved Sequentially9$254 Stars 4 Stars View Abstract
22-Jan-10Hilliard LyonsStephen A. O'NeilSituation Stabilizing, Outlook Improving8$254 Stars 4 Stars View Abstract
21-Jan-10Hilliard LyonsStephen A. O'NeilVery Strong Flu Test Sales Offset Weakness in a Key Product11$254 Stars 4 Stars View Abstract
15-Jan-10Hilliard LyonsStephen A. O'Neil2009 Revenue and EPS Expectations Lowered3$104 Stars 4 Stars View Abstract
11-Jan-10Hilliard LyonsStephen A. O'NeilCompany Agrees to Acquire K-Tron International6$254 Stars 4 Stars View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.